On September 12, 2019, in the laboratory, the auditors of VALARTIN PHARMA LLC conducted an external audit for the performance of services, according to the contract.

The purpose of the audit was to confirm the completion of the quality control of packaging materials, raw materials and finished medicines according to the physico-chemical, microbiological parameters in accordance with the requirements of DSTU ISO/IEC 17025:2017.

During the audit, the following were checked: documentation management, outsourcing, personnel, premises and equipment, testing, quality management.